Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCatenai Plc Regulatory News (CTAI)

Share Price Information for Catenai Plc (CTAI)

Share Price is delayed by 15 minutes
Get Live Data
0.225    0.00 (0.00%)
Bid:
0.21
Ask:
0.24
Spread: 0.03 (14.286%)
Market Cap: £3.23m
CTAI Live PriceLast checked at - London Stock Exchange

Intraday Catenai Plc Share Chart

Holding(s) in Company

16 Jan 2025 10:27

RNS Number : 6183T
Catenai PLC
16 January 2025
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BN7DVG54

Issuer Name

CATENAI PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Spreadex LTD

City of registered office (if applicable)

St. Albans

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

15-Jan-2025

6. Date on which Issuer notified

16-Jan-2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

9.793700

0.000000

9.793700

38643334

Position of previous notification (if applicable)

13.820000

0.000000

13.820000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BN7DVG54

38643334

9.793700

Sub Total 8.A

38643334

9.793700%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

CFD/Spreadbet

0

0.000000

Sub Total 8.B1

0

0.000000%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Lorenzo Dal Col01727 895144Spreadex is an FCA regulated provider of spread betting and CFD trading. Founded in 1999, Spreadex gives both retail and professional traders the opportunity to trade over 10,000 global markets, including UK small caps. For more information see www.spreadex.com/financials.

12. Date of Completion

16-Jan-2025

13. Place Of Completion

UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLPKABBKBKDQDD
12
Date   Source Headline
22nd May 20267:00 amRNSKlarian Update and Webinar
14th May 20267:00 amRNS-RAlludium VC Vertical Launch & Website Update
20th Apr 20267:00 amRNSContract Renewal and Klarian Update
2nd Apr 20267:00 amRNS-RAlludium Achieves Certifications
19th Mar 20267:00 amRNSAlludium secures first paying customers
13th Mar 20267:30 amRNSAlludium Further Investment, Warrants & Update
13th Mar 20267:30 amRNSAlludium Further Investment, Warrants & Update
19th Feb 20267:00 amRNS-RUpdate re Alludium
20th Jan 20267:00 amRNS-RNew Company Website
19th Jan 202612:32 pmRNSHolding(s) in Company
5th Jan 20267:00 amRNSKlarian update
19th Dec 20257:00 amRNS-RFurther re Investor Presentation
19th Dec 20257:00 amRNS-RFurther re Investor Presentation
11th Dec 20257:00 amRNS-RInvestor Presentation
1st Dec 20257:00 amRNS-RAlludium Update
11th Nov 20257:00 amRNS-RAlludium launches new website
4th Nov 20257:00 amRNSRepayment of Loan & Issue of Warrants
30th Oct 20257:00 amRNSAlludium Commercial Launch
30th Sep 20257:00 amRNSHalf-year Report
15th Sep 20257:00 amRNS-RSVV featuring Alludium in AI Webinar series
28th Jul 20257:00 amRNSUpdate on Treasury
17th Jul 20257:00 amRNSInvestment in Alludium
15th Jul 20253:15 pmRNSResult of GM & Issue of Equity
7th Jul 20257:00 amRNSAlludium “First Look” Event
1st Jul 20257:00 amRNSNotice of GM & Further Re Fundraise
30th Jun 20257:00 amRNSFinal Results & Klarian Update
26th Jun 20257:54 amRNSFundraise of up to £1.6m
16th Jun 20257:00 amRNS-RAlludium 'First Look' Investor Event in London
9th Jun 20257:00 amRNSAlludium Strategic Program Update
27th May 20257:00 amRNSAlludium accepted into NVIDIA Inception
21st May 20257:00 amRNSFurther re investment in Alludium, Issue of Equity
15th May 20257:30 amRNSLaunch of Alludium at LangChain’s AI Conference
13th May 20257:10 amRNSInvestment in Alludium
12th May 20251:23 pmRNSResult of AGM, Issue of Equity, Warrants
6th May 202510:37 amRNSProposed Issue of Warrants
30th Apr 20253:30 pmRNSInsurance Policy Renewal
29th Apr 20251:00 pmRNSExercise of Warrant
17th Apr 20253:34 pmRNSNotice of AGM & Proposed Share Sub-division
11th Apr 20257:00 amRNSProposed Investment in Alludium, Fundraise
8th Apr 202512:30 pmRNSHolding(s) in Company
7th Apr 20257:00 amRNSKlarian update
25th Mar 20257:00 amRNSDirector Disclosure Update
17th Jan 202511:58 amRNSHolding(s) in Company
16th Jan 202510:27 amRNSHolding(s) in Company
14th Jan 202512:37 pmRNSWorking Capital Loan and Related Party Transaction
13th Jan 202510:39 amRNSKlarian CLN Update
29th Nov 20247:00 amRNSInsurance Policy Renewal & RPT
28th Oct 20247:00 amRNSKlarian update
20th Sep 20247:00 amRNSHalf-year Report
28th Jun 20247:00 amRNSFinal Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.